Page last updated: 2024-10-22

albuterol and Carcinoma, Renal Cell

albuterol has been researched along with Carcinoma, Renal Cell in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barutca, S1
Meydan, N1
Barlak, A1

Other Studies

1 other study available for albuterol and Carcinoma, Renal Cell

ArticleYear
Prevention of interleukin-2-induced severe bronchospasm with salbutamol.
    Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine, 2003,Summer, Volume: 16, Issue:2

    Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchial Spasm; Bronchodilator Agents; Carcinoma,

2003